{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:21:17Z","timestamp":1791062477735,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T00:00:00Z","timestamp":1509408000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s11606-017-4205-9","type":"journal-article","created":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T18:23:05Z","timestamp":1509474185000},"page":"79-86","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Diabetes Screening among Antipsychotic-Treated Adults with Severe Mental Illness in an Integrated Delivery System: A Retrospective Cohort Study"],"prefix":"10.1007","volume":"33","author":[{"given":"Christina","family":"Mangurian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Schillinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Newcomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Vittinghoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Essock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Dyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Schmittdiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,31]]},"reference":[{"issue":"2","key":"4205_CR1","first-page":"A42","volume":"3","author":"CW Colton","year":"2006","unstructured":"Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prevent Chronic Dis. 2006;3(2):A42.","journal-title":"Prevent Chronic Dis."},{"key":"4205_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1471-244x-8-84","volume":"8","author":"DP Osborn","year":"2008","unstructured":"Osborn DP, Wright CA, Levy G, King MB, Deo R, Nazareth I. Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: systematic review and metaanalysis. BMC Psychiatry. 2008;8:84. https:\/\/doi.org\/10.1186\/1471-244x-8-84 .","journal-title":"BMC Psychiatry."},{"issue":"Suppl 1","key":"4205_CR3","first-page":"1","volume":"19","author":"JW Newcomer","year":"2005","unstructured":"Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs. 2005;19(Suppl 1):1-93.","journal-title":"CNS Drugs."},{"key":"4205_CR4","doi-asserted-by":"crossref","unstructured":"American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care; 2004. p. 596-601.","DOI":"10.2337\/diacare.27.2.596"},{"issue":"12","key":"4205_CR5","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1176\/appi.ps.60.12.1595","volume":"60","author":"SM Essock","year":"2009","unstructured":"Essock SM, Covell NH, Leckman-Westin E, Lieberman JA, Sederer LI, Kealey E, et al. Identifying clinically questionable psychotropic prescribing practices for Medicaid recipients in New York state. Psychiatr Serv. 2009;60(12):1595-602. https:\/\/doi.org\/10.1176\/appi.ps.60.12.1595 .","journal-title":"Psychiatr Serv."},{"issue":"1","key":"4205_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1001\/archgenpsychiatry.2009.179","volume":"67","author":"EH Morrato","year":"2010","unstructured":"Morrato EH, Druss B, Hartung DM, Valuck RJ, Allen R, Campagna E, et al. Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA\/APA recommendations for second-generation antipsychotic drugs. Arch Gen Psychiatry. 2010;67(1):17-24. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2009.179 .","journal-title":"Arch Gen Psychiatry."},{"issue":"12","key":"4205_CR7","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1001\/jamainternmed.2015.6098","volume":"175","author":"C Mangurian","year":"2015","unstructured":"Mangurian C, Newcomer JW, Vittinghoff E, Creasman JM, Knapp P, Fuentes-Afflick E, et al. Diabetes Screening Among Underserved Adults With Severe Mental Illness Who Take Antipsychotic Medications. JAMA Internal Med. 2015;175(12):1977-9. https:\/\/doi.org\/10.1001\/jamainternmed.2015.6098 .","journal-title":"JAMA Internal Med."},{"issue":"Suppl 4","key":"4205_CR8","first-page":"40","volume":"68","author":"BG Druss","year":"2007","unstructured":"Druss BG. Improving medical care for persons with serious mental illness: challenges and solutions. J Clin Psychiatry. 2007;68 Suppl 4:40-4.","journal-title":"J Clin Psychiatry."},{"issue":"6","key":"4205_CR9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3109\/09540261.2014.987221","volume":"26","author":"SA Esenwein von","year":"2014","unstructured":"von Esenwein SA, Druss BG. Using electronic health records to improve the physical healthcare of people with serious mental illnesses: a view from the front lines. Int Rev Psychiatry. 2014;26(6):629-37. https:\/\/doi.org\/10.3109\/09540261.2014.987221 .","journal-title":"Int Rev Psychiatry."},{"issue":"2","key":"4205_CR10","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1475-6773.2007.00779.x","volume":"43","author":"L Simoni-Wastila","year":"2008","unstructured":"Simoni-Wastila L, Zuckerman IH, Shaffer T, Blanchette CM, Stuart B. Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverage. Health Serv Res. 2008;43(2):496-514.","journal-title":"Health Serv Res."},{"issue":"4","key":"4205_CR11","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/jama.283.4.506","volume":"283","author":"BG Druss","year":"2000","unstructured":"Druss BG, Bradford DW, Rosenheck RA, Radford MJ, Krumholz HM. Mental disorders and use of cardiovascular procedures after myocardial infarction. Jama. 2000;283(4):506-11.","journal-title":"Jama."},{"issue":"5","key":"4205_CR12","first-page":"295","volume":"15","author":"JA Schmittdiel","year":"2009","unstructured":"Schmittdiel JA, Uratsu CS, Fireman BH, Selby JV. The effectiveness of diabetes care management in managed care. Am J Manag Care. 2009;15(5):295-301.","journal-title":"Am J Manag Care."},{"issue":"1","key":"4205_CR13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0895-4356(96)00268-5","volume":"50","author":"JF Steiner","year":"1997","unstructured":"Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50(1):105-16.","journal-title":"J Clin Epidemiol."},{"issue":"4","key":"4205_CR14","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/aje\/kws412","volume":"177","author":"D Westreich","year":"2013","unstructured":"Westreich D, Greenland S. The table 2 fallacy: presenting and interpreting confounder and modifier coefficients. Am J Epidemiol. 2013;177(4):292-8.","journal-title":"Am J Epidemiol."},{"issue":"7","key":"4205_CR15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/jama.2013.108769","volume":"310","author":"MG Jaffe","year":"2013","unstructured":"Jaffe MG, Lee GA, Young JD, Sidney S, Go AS. Improved blood pressure control associated with a large-scale hypertension program. Jama. 2013;310(7):699-705.","journal-title":"Jama."},{"key":"4205_CR16","doi-asserted-by":"crossref","first-page":"i6538","DOI":"10.1136\/bmj.i6538","volume":"356","author":"E Barry","year":"2017","unstructured":"Barry E, Roberts S, Oke J, Vijayaraghavan S, Normansell R, Greenhalgh T. Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions. BMJ. 2017;356:i6538.","journal-title":"BMJ"},{"issue":"16","key":"4205_CR17","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1001\/jama.2009.1549","volume":"302","author":"CU Correll","year":"2009","unstructured":"Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA. 2009;302(16):1765-73. https:\/\/doi.org\/10.1001\/jama.2009.1549 .","journal-title":"JAMA."},{"key":"4205_CR18","doi-asserted-by":"crossref","unstructured":"Bobo WV, Cooper WO, Stein CM, Olfson M, Graham D, Daugherty J, et al. Antipsychotics and the risk of type 2 diabetes mellitus in children and youth. JAMA Psychiatry. 2013;70(10):1067-75. https:\/\/doi.org\/10.01\/jamapsychiatry.2013.53 .","DOI":"10.1001\/jamapsychiatry.2013.2053"},{"key":"4205_CR19","doi-asserted-by":"publisher","unstructured":"Correll C, Robinson D, Schooler N, Brunette M, Mueser K, Rosenheck R, et al. Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disordrers. JAMA Psychiatry. 2014. https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.1314 .","DOI":"10.1001\/jamapsychiatry.2014.1314"},{"issue":"4 Suppl","key":"4205_CR20","first-page":"S39","volume":"190","author":"TJ Lambert","year":"2009","unstructured":"Lambert TJ, Newcomer JW. Are the cardiometabolic complications of schizophrenia still neglected? Barriers to care. Med J Aust. 2009;190(4 Suppl):S39-42.","journal-title":"Barriers to care. Med J Aust."},{"issue":"6","key":"4205_CR21","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1176\/appi.ps.002542012","volume":"64","author":"C Mangurian","year":"2013","unstructured":"Mangurian C, Giwa F, Shumway M, Fuentes-Afflick E, Perez-Stable EJ, Dilley JW, et al. Primary care providers\u2019 views on metabolic monitoring of outpatients taking antipsychotic medication. Psychiatric Services. 2013;64(6):597-9. https:\/\/doi.org\/10.1176\/appi.ps.002542012 .","journal-title":"Psychiatric Services."},{"issue":"2-3","key":"4205_CR22","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.schres.2012.08.031","volume":"143","author":"SG Parameswaran","year":"2013","unstructured":"Parameswaran SG, Chang C, Swenson AK, Shumway M, Olfson M, Mangurian CV. Roles in and barriers to metabolic screening for people taking antipsychotic medications: a survey of psychiatrists. Schizophrenia Research. 2013;143(2-3):395-6. https:\/\/doi.org\/10.1016\/j.schres.2012.08.031 .","journal-title":"Schizophrenia Research."},{"issue":"2","key":"4205_CR23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2105\/AJPH.2005.083501","volume":"98","author":"AJ Karter","year":"2008","unstructured":"Karter AJ, Stevens MR, Gregg EW, Brown AF, Tseng C-W, Marrero DG, et al. Educational disparities in rates of smoking among diabetic adults: the translating research into action for diabetes study. Am J Public Health. 2008;98(2):365-70.","journal-title":"Am J Public Health"},{"issue":"1","key":"4205_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.genhosppsych.2008.07.007","volume":"31","author":"S Himelhoch","year":"2009","unstructured":"Himelhoch S, Leith J, Goldberg R, Kreyenbuhl J, Medoff D, Dixon L. Care and management of cardiovascular risk factors among individuals with schizophrenia and type 2 diabetes who smoke. Gen Hosp Psychiatry. 2009;31(1):30-2. https:\/\/doi.org\/10.1016\/j.genhosppsych.2008.07.007 .","journal-title":"Gen Hosp Psychiatry."},{"issue":"9","key":"4205_CR25","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.2337\/diacare.24.9.1590","volume":"24","author":"SG Wannamethee","year":"2001","unstructured":"Wannamethee SG, Shaper AG, Perry IJ. Smoking as a modifiable risk factor for type 2 diabetes in middle-aged men. Diabetes Care. 2001;24(9):1590-5.","journal-title":"Diabetes Care."},{"issue":"4","key":"4205_CR26","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1093\/schbul\/sbp152","volume":"37","author":"DL Kelly","year":"2011","unstructured":"Kelly DL, McMahon RP, Wehring HJ, Liu F, Mackowick KM, Boggs DL, et al. Cigarette smoking and mortality risk in people with schizophrenia. Schizophr Bull. 2011;37(4):832-8. https:\/\/doi.org\/10.1093\/schbul\/sbp152 .","journal-title":"Schizophr Bull."},{"key":"4205_CR27","unstructured":"Ash JS, Sittig DF, Campbell EM, Guappone KP, Dykstra RH, editors. Some unintended consequences of clinical decision support systems. AMIA; 2007."},{"key":"4205_CR28","unstructured":"National Committee for Quality Assurance. HEDIS Measures. 2017. http:\/\/www.ncqa.org\/hedis-quality-measurement\/hedis-measures ."},{"issue":"2","key":"4205_CR29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.genhosppsych.2014.12.005","volume":"37","author":"JQ Young","year":"2015","unstructured":"Young JQ, Kline-Simon AH, Mordecai DJ, Weisner C. Prevalence of behavioral health disorders and associated chronic disease burden in a commercially insured health system: findings of a case\u2013control study. Gen Hosp Psychiatry. 2015;37(2):101-8.","journal-title":"Gen Hosp Psychiatry."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11606-017-4205-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-017-4205-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-017-4205-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T23:52:21Z","timestamp":1659743541000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11606-017-4205-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,31]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["4205"],"URL":"https:\/\/doi.org\/10.1007\/s11606-017-4205-9","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,31]]}}}